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     The main activity of lactic acid bacteria (LAB) 
during fermentation is the catabolism of sugars 
present in food, producing lactic acid by homo- 
or heterofermentative pathways. In addition, these 
microorganisms also have the capability to metabolize 
other substrates, such as citrate. Citrate is present in 
fruit juices, milk and vegetables and is also added as 
a preservative to foods. Citrate fermentation by LAB 
leads to the production of 4-carbon compounds, mainly 
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diacetyl, acetoin and butanediol, which have aromatic properties. One of these 
compounds, diacetyl is responsible for the buttery aroma of dairy products 
such as butter, acid cream and cottage cheese. In addition, it is an important 
component of the flavour of different kinds of chesses and yoghurt. Moreover, 
the CO2 produced as a consequence of citrate metabolism contributes to the 
formation of "eyes" (holes) in Gouda, Danbo and other cheeses. Thus, the 
utilization of citrate in milk by LAB has a very positive effect on the quality of 
the end products. Therefore, the interest of the dairy industry in controlling  
citrate utilization by LAB has promoted research into the proteins and 
effectors controlling its metabolic pathway. In this chapter we summarize the 
current knowledge of citrate utilization by LAB. The transport of citrate and its 
metabolism to pyruvate, as well as further conversion to aroma compounds, is 
described and, the differences in the co-metabolism of citrate with glucose 
between homo or heterofermentative bacteria is discussed. In addition, the 
molecular mechanisms controlling expression of genes responsible for 
transport and conversion of citrate into pyruvate are presented, as are their 
correlation with the physiological function of citrate metabolism. To date, two 
different models of regulation have been described which are unique to LAB. 
In Lactococcus lactis, a specific transcriptional activation of the promoters 
controlling the cit operons takes place at low pH to provide an adaptative 
response to acidic stress. In Weissella paramesenteroides, the CitI 
transcriptional regulator functions as a citrate-activated switch allowing the 
cell to optimize the generation of metabolic energy. CitI, its operators and 
citrate transport and metabolic operons are highly conserved in several LAB. 
Therefore, this mechanism of sensing and response to citrate appears to have 
been conserved and propogated during the evolution of LAB. 
 
2. Introduction 
 Analysis of a large set of bacterial genomes has shown that, in spite of its 
high occurrence in nature, only a limited number of bacteria are able to 
ferment citrate [1]. Citrate is of course the key intermediate in the Krebs’ cycle 
(tricarboxylic acid cycle) which is very widely spread in all major classes of 
aerobic organisms. However, some bacterial species possess alternative 
metabolic pathways for the metabolism of citrate under anaeobic or aerobic 
conditions. Citrate fermentation can be carried out in the presence of oxygen 
when bacteria lack, or possess a defective Krebs’ cycle (such is the case of 
LAB), or in anaerobiosis, when this cycle is not completely functional. Citrate 
fermentation can produce a variety of metabolic products (Fig. 1) depending 
on the genus of the bacteria and the growth conditions. In all cases, citrate 
fermentation involves the transport of this compound through a specific 
membrane protein and its subsequent conversion into acetate and oxaloacetate 
catalyzed by the enzyme citrate lyase. In most bacteria including LAB an  
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Figure 1. Citrate utilization pathways in bacteria and its end products. Citrate 
fermentation requires a specific membrane transporter (T), a citrate lyase activity (CL) 
and in most of the bacterial systems an oxaloacetate decarboxylase activity (OAD). The 
initial products of the pathway are acetate, CO2 and pyruvate. The end products will be 
different depending on the micro-organism and the conditions of the fermentation (see 
details in the text). 
 
oxaloacetate decarboxylase converts oxaloacetate into pyruvate, whose 
metabolism yields various compounds (Fig. 1). Among them, the aroma 
compound diacetyl has special interest for the dairy industry. 
 Strains of Lactococcus lactis subspecies lactis biovariety diacetylactis    
(L. diacetylactis), and some species belonging to Leuconostoc and Weissella 
genera are used as diacetyl producers by dairy industry. Thus, most of the 
knowledge of LAB citrate utilization has been derived from these dairy 
bacteria, and they will be the central topic of this review. In addition, in 
traditional cheeses Enterococcus species contribute to the aroma by fermenting 
citrate. Moreover, other bacteria such as Lactobacillus plantarum and 
Oenococcus oeni frequently use citrate present in the culture media and 
produce secondary fermentation in wine, beer and sausages. In these cases 
high concentration of diacetyl confers to the products a deleterious butter taste 
and affect negatively to the flavour of the product. Therefore, information 
regarding other LAB will be also presented in this chapter. Finally, the 
molecular organization and regulation of expression of the genes required for 
citrate degradation in these bacteria will be described. 
 
3. The aroma compounds biosynthetic pathway from 
citrate 
 In LAB, citrate metabolism, like glucolysis, leads to the formation of 
pyruvate. The synthesis of pyruvate from citrate requires three steps: citrate 
transport by a permease, its conversion into oxaloacetate by citrate lyase (CL), 
and further conversion of oxaloacetate into pyruvate and CO2 by the 
oxaloacetate decarboxylase (OAD) (Figs. 1 and 2). These three steps will be described 
in detail below. Metabolism of pyruvate can yield in LAB different end-
products such as lactate, formate, acetate, ethanol and the aroma compounds of  
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Figure 2. C4-compound biosynthetic pathway in LAB. The degradation pathways in 
the genera Lactococcus and Leuconostoc. Enzymes involved in the pathway: 1, citrate 
lyase; 2, oxaloacetate decarboxylase; 3, lactate dehydrogenase; 4, pyruvate 
decarboxylase; 5, acetolactate synthase; 6,acetolactate decarboxylase; 7, non enzymatic 
oxidative decarboxylation of α-acetolactate; 8 and 9, diacetyl acetoin reductase; 10, 
2,3-butanediol dehydrogenase;. TPP, thiamine pyrophosphate. 
 
four carbons (C4 compounds) diacetyl, acetoin y butanediol ([2] and Figs. 1 
and 2). In the early 1980s, it was established that citrate is required specifically 
for efficient diacetyl and acetoin synthesis in LAB (reviewed in [3]). Also it 
was postulated, that in these bacteria the C4 compounds are produced to 
eliminate toxic amounts of pyruvate, which are produced under particular 
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growth conditions (reviewed in [3]). Similarly, excess pyruvate could occur in 
mutant strains deficient in lactate dehydrogenase, the enzyme which catalyzes 
the conversion of citrate into lactate, since it was observed that in these micro-
organisms high amounts of diacetyl are formed (reviewed in[2]). 
 The metabolic biosynthetic pathway from citrate to diacetyl was revealed 
in L. diacetylactis by use of nuclear magnetic resonance (NMR) techniques [4, 
5]. Ramos et al. [5] demonstrated that the main route of diacetyl synthesis is 
via the intermediary α-acetolactate (Fig. 2). α-Acetolactate synthase (α-ALS) 
is the key enzyme in the synthesis of C4 compounds by catalyzing the 
condensation of two pyruvate molecules to generate α-acetolactate. Studies 
carried out with different strains of L. lactis showed that α-ALS has a low 
affinity for pyruvate (Km between 30 to 50 mM), and an optimal pH of 6.0. 
Therefore, synthesis of α-acetolactate is favoured under conditions of pyruvate 
excess and acidic pH, which has been shown to increase production of C4 
aroma compounds [6, 7]. Once synthesized, α-acetolactate is unstable and is 
readily decarboxylated to acetoin by α-acetolactate decarboxylase (α-ALD), or 
by non-enzymatic decarboxylation (in the presence of oxygen) to diacetyl. 
Acetoin can be also synthesized from diacetyl by diacetyl reductase (DAR) [8]. 
This enzyme also possesses an acetoin reductase activity, which yields 2,3 
butanediol from acetoin, being the reverse reaction catalyzed by 2,3 butanediol 
dehydrogenase (BDH). The DAR of L. lactis requires NADH, while its 
counterpart in Leuconostoc uses NADPH. Thus, the balance between the end 
products of citrate fermentation (diacetyl, acetoin and 2,3 butanediol) will 
depend on the redox state of the cells [9]. Once synthesized, these C4 
compounds are secreted without requiring specific transporters. 
 
4. Citrate transporters 
 The limiting step for the utilization of extracellular citrate is the 
requirement for specific transporters, which facilitate its entrance into the cells. 
Biochemical characterization of citrate permeases has shown that citrate can be 
taken up by diverse mechanisms and they have been classified into different 
families. The bacterial citrate transporters occur in four different families 
(Table 1) which have been named: the metabolite:proton symporters (MHS); 
the citrate:cation symporters (CCS); the 2-hydroxycarboxylate transporters (2-
HCT); and the citrate:metal symporters (CitMHS). 
 The MHS family, which belongs to the major facilitator superfamily 
(MFS) of transporters, includes permeases utilized by enterobacteriaceae 
during aerobic citrate fermentations (Table 1). These transporters are the CitH 
of Klebsiella pneumoniae and the CitAs of Escherichia coli and Salmonella 
typhimurium. They are symporters, which transport one molecule of citrate and 
three protons.  
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Table 1. Families that include citrate secondary transporters in bacteria. 
 
 
(*) Only systems of citrate transport, and not the members of these families associated to the 
transport of other compounds, will be mentioned. 
 
 The CCS family includes the CitT of E. coli which transports citrate 
under anaerobic conditions, and its proposed mechanism of action involves an 
antiport of citrate and succinate, the end-product of citrate metabolism in this 
bacterium [27]. 
 The 2HCT family includes transporters of dicarboxylic and tricarboxylic 
acids [1]., Among the citrate transporters of this family are included the well 
characterized K. pneumoniae CitS permease, and the CitP permeases of 
Lactococcus, Leuconostoc and Weissella (Table 1). The transporters of 
Klebsiella and of LAB utilize a different mechanism to take up citrate. CitS is 
a symporter which uses a Na2+-gradient to transport citrate, whereas CitP is 
responsible for the antiport of H-citrate2- and lactate1- generating a membrane 
potential (see below). In LAB the genes encoding the CitP citrate permease were 
identified in plasmids (Table 1 and Fig. 3). The citP genes so far identified have 
a 99% sequence homology, suggesting a recent acquisition of this gene by 
horizontal transfer [28]. These genes are located in unrelated plasmids in L. lactis,  
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Figure 3. Physical organization of genes encoding proteins involved in citrate 
transport and conversion into pyruvate. The cit genes of the indicated bacteria are 
depicted. Genes encoding proteins, which regulate expression of cit genes are also 
shown (see details in the text). Genes with various functions are indicated by boxes: 
black, citrate transport, grey, citrate metabolism and white, regulation of gene 
expression. Plasmidic (Pl) or chromosomal (Chr) location of the cit clusters is 
indicated. O1 and O2, operators of the CitI regulador. The O2 operator TTTTAAA-AA-
TTTAAAA with perfect matched inverted repeats, corresponds to a high affinity site, 
whereas the O1 operator TTTTAAA-AA-TTTGAAC corresponds to the site recognised 
with less affinity by the regulator. 
 
W. paramesenteroides and Lc. mesenteroides. In W. paramesenteroides the 
genes encoding OAD and CL constitute, with citP, the citMCDEFXG operon 
([29] and Fig. 3). In L. lactis the coding genes of the enzymes implicated in 
citrate metabolism are located in the chromosome (Fig. 3) and only citP, 
included in the citQRP citrate transport system operon[30], is located in a 
plasmid [17]. 
 The CitMHS family constitutes a new group of citrate transporters that 
have been recently described (Table 1). This group of permeases is associated 
with the aerobic metabolism of citrate and includes the transporters CitM and 
CitH of Bacillus subtilis [24]. Both permeases transport citrate complexed with 
metal ions; CitM takes up citrate in complex with Mg2+, whereas CitH 
transports the complex of citrate and Ca+2. To this family also belong citrate 
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permeases of LAB, CitM of Streptococcus mutans [25] and CitH of 
Enterococcus faecalis [26]. Although the enterococcal CitH shares 75% 
sequence homology with the streptococcal CitM, the uptake of citrate complex 
is different in these micro-organisms. In En. faecalis citrate is co-transported 
with Ca2+ (also Mn2+ but not Fe2+or Fe3+), whereas for S. mutant it has been 
proposed that citrate is transported complexed to Fe3+ (also Mn+2 but not Ca2+ 
or Mg2+ ). In contrast to LAB carrying CitP transporters, in S. mutans and En. 
faecalis the genes encoding either the CitM or CitH permeases are located in 
the chromosome associated to the citrate fermentation clusters (Table 1 and 
Fig. 3). These chromosomal gene clusters for citrate transport and metabolism 
are also detected in K. pneumoniae citS and E. coli citT (Fig. 3). 
 Two further systems of citrate transporters in Lactobacillus and 
Oenococcus have not been fully characterized. However, two genes exist in the 
O. oeni chromosome, that by homology encode organic acid transporters, 
which could be the citrate transporters of this micro-organism. The maeP 
located within the citrate metabolism cit (citM-maeP-citCDEFXG) cluster 
(Fig. 3) and the unlinked yaeP, whose expression is induced by the presence of 
citrate in the growth medium [31]. In Lb. plantarum, upstream of the gene 
cluster encoding CL and OAD, and with divergent polarity, is located the      
lp-1102 gene (Fig. 3), whose product has homology to cation transporters and 
that could be the citrate permease of this bacteria. 
 
5. Conversion of citrate into pyruvate 
 The CL is an enzymatic complex, which catalyzes the conversion of citrate 
in acetate and oxaloacetate in a multi-reaction process (Fig. 4). This reaction is 
the initial step in all citrate fermentation pathways known in bacteria. The 
holoenzyme has been purified and characterized in several species, but most of 
the studies have been carried out with the K. pneumoniae enzyme [27]. In this 
micro-organism the CL consists of three different subunits, α (54.7 kDa), β 
(31.4 kDa) and γ (11.4 kDa), associated in a stoichiometric relationship of 
α6β6γ6 (550 kDa). The α and β subunits are responsible for the catalytic 
activity of CL. The γ subunit contains the prosthetic group triphosphoribosyl-
dephospho-coenzyme A, which lacks any intrinsic enzymatic activity, and acts 
as acyl transporter protein (ACP) [27]. Figure 4 shows a scheme of the steps 
catalyzed by each subunit. In the first step the α-subunit (acetyl-ACP:citrate 
ACP-transferase) catalyzes the interchange between the acetyl group (linked to 
the prosthetic group of the enzyme) and the citryl group to generate acetate and 
citryl-S-ACP. Subsequently, the β-subunit (citryl-S-ACP oxaloacetate-lyase) 
catalyzes the regeneration of acetyl-S-ACP, releasing oxaloacetate from the 
citryl-S-ACP. The catalytic activity of CL requires the activation of the 
prosthetic group and for this, it is necessary to convert its thiol group to an  
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Figure 4. Reaction catalyzed by the citrate lyase complex and reactions involved in 
the synthesis and activation of its prosthetic group. CL converts citrate into 
oxaloacetate and pyruvate in a process consisting of two hemi reactions. The first is 
catalyzed by the acetyl-ACP:citrate ACP-transferase (α-subunit), while the second is 
driven by citryl-S-ACP oxaloacetate-lyase (β-subunit). The γ-subunit has the prosthetic 
group linked to serine 14 and acts as an acyl transporter protein. The steps of biosynthesis 
and linking of the prosthetic group (catalyzed by CitG and CitX, respectively) to the        
γ-subunit are also shown. The activation of the prosthetic group is produced by 
acetylation, catalyzed by the enzyme acetate:SH-citrate lyase ligase (CitC). HS-R 
represents the prosthetic group triphosphoribosyl-dephospho-coenzyme A. 
 
acetyl thioester. This enzymatic reaction is catalyzed by the acetate:SH-citrate 
lyase ligase (CitC) in the presence of acetate and ATP [27]. Studies in E. coli 
and K. pneumoniae showed that a protein named CitX (20.4 kDa) catalyzes the 
formation of the holo-ACP by linking the prosthetic group triphosphoribosyl-
dephospho-coenzyme A to the apo-ACP. Furthermore, this prosthetic group is 
synthesized from ATP and dephospho-coenzyme A in a process catalyzed by 
the protein CitG (25.2 kDa) [32]. In E. coli, these two latter proteins were 
designated: CitX: apo-citrate lyase phosphoribosyl-dephospho-coenzyme A 
transferase, CitG: triphosphoribosyl-dephospho-coenzyme A synthase. In this 
chapter CitC, CitX and CitG will be referred to as accessory proteins (required 
for the activity of CL). 
 CL and its coding genes have been investigated in LAB. CL has been 
purified from a Lc. mesenteroides 195 strain and its activity established [33]. 
The coding genes have been cloned and characterized from a genomic library 
of Lc. mesenteroides 195 [33], from a plasmid belonging to the J1 strain of W. 
paramesenteroides [16, 29], and also from the chromosome of L. diacetylactis 
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CRL264 [34]. In the genomes of these LAB, as in K. pneumoniae, it is possible 
to find citD, citE and citF genes (Fig. 3), which encode the γ-, β- and α-
subunits of the CL complex. Genomic analysis has shown that in O. oeni, En. 
faecalis and some species of Lactobacillus (i.e. acidophilus and casei) the CL 
coding genes are present. However, the analysis of  L. lactis genomes revealed 
that only the strains belonging to subsp. lactis, and not those of subsp. 
cremoris, possess CL. This correlates with the fact that L. cremoris is not able 
to metabolize citrate. Comparison of the amino acid sequences of CitC, CitE 
and CitF from L. diacetylactis with their homologues in others micro-
organisms revealed the existence of an elevated conservation for the three CL 
subunits in bacteria. Moreover, the analysis identified a conserved region in all 
the sequenced γ-subunits. This region, with the sequence 9-AGTLESSDV-17, 
includes the residue serine 14, to which the prosthetic group 2`-(5`-
phosphoribosyl)-3`-dephospho-CoA [32] is bound. Flanking the L. 
diacetylactis CL genes are citC (upstream) and, citG and citX (downstream) 
(Fig. 4), which encode the accessory proteins responsible, respectively, for the 
biosynthesis, the assembly, and the acetylation of the prosthetic group of the 
enzyme. CitX and citG can be found as independent genes, e. g. L. lactis or O. 
oeni, or as part of one gene (named citG*), as occurs in Lc. mesenteroides, W. 
paramesenteroides and K. pneumoniae. For this last case, the product of the 
hybrid gene is a single, bi-functional polypeptide, which possesses both 
enzymatic activities (CitX activity in the N-terminal and CitG activity in the  
C-terminal). 
 The second step of citrate metabolism, catalyzed by OAD, is the 
decarboxylation of oxaloacetate synthesised by CL, generating pyruvate and 
CO2. The best characterized bacterial oxaloacetate decarboxylase is the 
enzyme of K. pneumoniae, a biotinylated multi-enzymatic  complex attached 
to the membrane (Fig. 5), and encoded  by the  oadGAB genes (Fig. 3). OAD is 
composed of two integral membrane subunits β and γ. (encoded by oadB and 
oadG). The α-subunit (encoded by oadA) is the decarboxylase and it is 
composed of two domains α and δ. The δ-domain is the biotin acceptor and 
contains the prosthetic group which binds to the [1-C]-carboxyl group of 
oxaloacetate in a reaction catalyzed by the α-domain. Finally, decarboxylation 
of the carboxybiotin group is coupled to Na+ translocation by the β-subunit. 
Thus, OAD couples the exergonic reaction of decarboxylation of oxaloacetate 
to pyruvate with the electrogenic transport of sodium ions out of the cell, 
which generates an electrochemical gradient of Na+ (∆µNa+) through the 
membrane. 
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Figure 5. Oxaloacetate decarboxylase complex. Left, the membrane biotin 
decarboxylase from K. pneumoniae; Right, putative oxaloacetate decarboxylase present 
in En. faecalis and other LAB. 
 
 This system constitutes a primary mechanism of energy generation that has 
been studied in depth [27]. Analysis of the genomes of various LAB indicate that 
a homologue of the K. pneumoniae OAD is present in S. mutans and En. faecalis 
(Fig. 5) as well as in Lactobacillus sakei and Lb. casei. In micro-organisms 
belonging to Firmicutes, the oadA, oadB and oadD genes, encode the α-, β- and 
δ-subunits of the oxaloacetate decarboxylase. The physiological role of the OAD 
complex remains to be studied in this group of micro-organisms, and it should be 
noted that in Firmicutes the two functional domains of the α-subunit from K. 
pneumoniae are divided in two different subunits. 
 Upstream of the genes encoding CL in W. paramesenteroides, Lc. 
mesenteroides, L. diacetylactis, Lb. plantarum and O. oeni (Fig. 3), there is a 
gene (named citM for Weissella [29] or mae [33, 35] for the other LAB), which 
encodes a 40 kDa polypeptide [16, 33, 35]. This polypeptide, by amino acid 
homology, belongs to the malic enzyme family (MEF) and could be the OAD 
of these bacteria. Moreover, the co-transcription of citM with CL genes was 
detected in Leuconostoc, Weissella and L. lactis [29,33, 34], supporting that 
CitM could play the role of a soluble OAD. 
 The product of the citM gene from L. diacetylactis was expressed and 
biochemical studies demonstrated that this enzyme has specific oxaloacetate 
decarboxylase activity [36]. The comparative analysis among members of the 
MEF revealed that the CitM from various LAB contain conserved active site 
residues such as the Tyr residue (Y36) and Lys residue (K91) proposed to be 
involved in the general acid-base mechanism (Fig. 6). Furthermore, the 
Glu(E133) and Asp (D134 and D159) residues required for the divalent cation-  
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Figure 6. Putative catalytic mechanism for the soluble oxaloacetate decarboxylase 
(citM product) associated with citrate metabolism. Conserved residues are indicated 
(see details in the text). 
 
binding site, and two Rossmann Domains (GXGXXG), are highly conserved in 
all members of the MEF. These functional conservations indicate a common 
mechanism for oxaloacetate decarboxylation. 
 
6. Regulation of citrate transport and conversion 
into pyruvate 
 The genes involved in the transport and conversion of citrate into pyruvate 
are grouped together in the chromosomes of different micro-organisms (Fig. 
3). In K pneumoniae oadGAB genes, which encode the OAD complex, the citS 
gene encoding for the citrate transporter, and the regulatory genes citAB, 
constitute an operon. Adjacent to this operon, and with divergent polarity, is 
transcribed the citCDEFG operon which is responsible for the synthesis of the 
proteins involved in the first step of citrate metabolism [27]. The citA and citB 
gene encodes the CitA and CitB proteins, which constitute a signal 
transduction two component system (TCS). In this system CitA is the sensor 
kinase, while CitB is the response regulator [27]. The system regulates its own 
expression as well as the expression of the citS gene and the citCDEFG and 
oadGAB operons (Fig. 3). Transcription is stimulated by the presence of 
citrate, low oxygen levels, the presence of sodium ions and alternative carbon 
sources other than citrate in the culture medium. The citrate fermentation genes 
are subject to catabolite repression exerted by the cAMP receptor protein Crp 
[27]. In E. coli the genes encoding the CitT permease (citT), the CL complex 
and its accessory proteins (citCDEFXG) as well as the TCS (citAB), are also 
grouped in the chromosome ([13] and Fig 3), and their expression presumably 
is also controlled by the TCS. This mechanism of regulation is also functional 
in B. subtilis, in which the CitST TCS (a member of the CitAB family) is 
involved in the regulation of the expression of genes encoding the citrate 
transporters required for the utilization of citrate in aerobic conditions 
[37,38,39]. 
Aroma production from citrate 13 
 The above quorum sensing molecular mechanism of regulation of citrate 
utilization does not appear to exist in LAB and we have described two 
different transcriptional regulatory circuits for these micro-organisms. In W. 
paramesenteroides, upstream of the citMCDEFGRP operon (which encodes 
CitM, CL and CitP), is located, with divergent polarity, the citI gene ([16,29] and 
Fig. 3). Transcription of the operon and citI from Pcit and PcitI promoters is 
induced upon addition of citrate to the growth medium [29]. Complementation 
experiments revealed that the presence of citI in cis and in trans resulted in an 
increased transcription from Pcit [29]. Characterization of CitI by DNA-protein 
interaction and in vitro transcriptional studies revealed that the protein is a 
transcriptional activator directly controlled by citrate and specifically involved in 
citrate metabolism, which induces its own transcription and that of the cit operon 
[40]. CitI is able to bind co-operatively to two operators O1 (high affinity) and 
O2 (low affinity) located between PcitI and Pcit (Fig. 3). Moreover, citrate 
increases the affinity of CitI to these operators, as well as enhancing the 
formation of Pcit-RNA polymerase (RNAP)-CitI ternary complex. 
 Based on the the above results, we have proposed the following model of 
regulation for CitI [40]. In the absence of citrate, CitI would bind to the 
operator sites stimulating the RNAP to form complexes on both promoters. 
This would result in low expression levels of the citrate fermentation enzymes 
as well as of the citrate permease P, which would catalyze the uptake of citrate 
when this compound becomes available in the external environment. Once 
transported inside the cell, citrate would bind to CitI enhancing the regulator 
affinity for its DNA operators and resulting in increased RNAP recruitment at 
Pcit and PcitI. This would result in transcriptional activation from both 
promoters. Activation of Pcit results in coordinated synthesis of the citrate 
fermentation enzymes and breakdown of citrate. The levels of citI and cit 
mRNAs in vivo are approximately 2.5- and 20-fold higher in cultures grown in 
the presence of citrate. Consequently, it seems that a small increase in CitI 
transcription could account for the large increase of the cit mRNA detected in 
W. paramesenteroides growing in a citrate-supplemented medium. The 
Weissella genetic organization of citI and the cit operon, and identical CitI 
operators, are also present in species of Leuconostoc, Lactobacillus and 
Oenococcus (Fig. 3). Consequently, it is probable that the mechanism of 
regulation of gene expression mediated by Cit I and citrate active in Weissella 
is also functional in these bacteria. Supporting this hypothesis, the transcription 
of the Leuconostoc cit operon is induced by the presence of citrate in the 
growth medium [41]. 
 A citMCDEFXG (cit) operon occurs in the L. diacetylactis chromosome 
which encodes CitM and CL. This operon does not include the citrate 
permease citP; this latter gene is part of the citQRP operon which is located in 
a plasmid ([30] and Fig. 3). The citQRP operon is transcribed from the P1 
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promoter located 1 kb upstream of citQ [30], whereas the Pcit promoter 
located upstream of citM drives transcription of the cit operon ([34] and Fig. 
3). A citI gene is also present in the lactococcal chromosomal cit region, with 
divergent polarity to the cit operon, but located between citM and citC (Fig. 3). 
An O1 operator is present upstream of the PcitI promoter, indicating that the 
regulator could control its own synthesis. However, an O2 operator for CitI 
does not exist upstream of Pcit. This could be the reason why transcription 
from Pcit, as for P1 [42], is not affected by the presence of citrate in the growth 
medium [34]. Interestingly, in this bacterium transcription from promoters Pcit 
and P1 is induced by growth under acidic conditions [34, 43]. Thus, it seems 
that when L. lactis cells detects a decrease in external pH, transcription of 
citQRP and citMCDEFXG operons increases in synchrony. As a consequence 
citrate is efficiently transported and converted into pyruvate. In addition, 
expression of the citMCDEFXG operon could trigger another circuit of 
transcriptional regulation mediated by CitI. We have detected that synthesis of 
citI mRNA also increases upon growth at acidic pH (unpublished results). This 
would result in increased levels of CitI, which could complex with the 
incoming citrate. The CitI-citrate complex, once bound to O1, would recruit 
RNAP, activating transcription from the PcitI promoter. It is worth noting that 
citI is located between the CitM and CL coding genes, and that the cit 
transcript includes the sequence complementary to the citI mRNA. Therefore, 
under steady state acidic conditions transcription of citI could down regulate 
expression of the CL coding genes. This could take place by collision of 
convergent rounds of transcription from Pcit and PcitI or by an antisense 
mechanism. 
 In addition to the transciptional regulation provoked by acidic stress, there 
exist several mechanisms of regulation that affect the lactococcal citQRP 
citrate transport operon. As stated above in, L. lactis the operon is transcribed 
from the pH dependent P1 promoter (Fig. 3). In addition, it seems that 
introduction of the 1 kb insertion sequence IS982 has generated a 
transcriptional promoter, named P2 (Fig. 3), which supports expression of the 
operon in E. coli [44]. In the citrate transport operon, only the citrate permease 
structural gene is required for citrate transport [45]. The citQ and citR genes 
seem to be involved in regulation of expression of CitP. Expression of citQ has 
been confirmed by in vivo analysis of translational fusions and by detection of 
the 3.5 kDa small CitQ polypeptide after synthesis by in vitro transcription and 
translation (unpublished results). Analysis of the influence of CitR on 
expression of CitP performed in L. lactis and E. coli indicate that CitR is a 
repressor, which controls the levels of CitP without affecting mRNA levels 
[30,46]. The 3´-region of citQ and the 5´-region of citR overlap and form a 
complex secondary structure. Analysis of the fate of the citQRP mRNA 
revealed that in L. diacetylactis and in E. coli the citQRP transcripts are 
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subjected to endonucleolytic cleavage at this location [30, 47]. Two 
endoribonucleases RNase III and RNase E catalyze the specific cleavages 
within the secondary structure, respectively upstream and at the ribosomal 
binding site of CitR [46,48]. In L. lactis the enzymes involved in the 
processing have not been identified. However, RNase III is ubiquitous and the 
enzyme and its activity on double stranded regions located in stem-loop 
structures have been identified in L. lactis [46, 49]. Determination of the 
genome sequence of various gram-positive bacteria has not shown the 
existence of a homologue of E. coli rne which encodes RNase E. However, 
results from our and other laboratories support that RNase E activity exists in 
L. lactis and B. subtilis. Therefore, it seems that analogues but not homologous 
to E. coli RNase E exist in gram-positive bacteria. The overall results allowed 
us to postulate the following mechanism of post-transcriptional regulation of 
citQRP expression. CitQ is a small peptide whose translation could compete 
with the formation and processing of the secondary structure by 
endoribonucleases, thereby modulating the level of the post-transcriptional 
regulator CitR, which controls translation of CitP. 
 
7. Bioenergetics of citrate metabolism 
 Most of the knowledge on the metabolic pathways involved in citrate 
metabolism has been derived from LAB of dairy origin, although citrate itself 
does not always support their growth. This claim is based on the inability of 
certain LAB to grow in batch cultures to which citrate was added as the sole 
energy source. Nevertheless, most LAB are able to co-metabolize citrate in the 
presence of another energy source, such as glucose or lactose. Co-metabolism 
of citrate and sugar is of importance for food quality, as citrate and sugar are 
both present in fermented food products, such as during the fermentation of 
milk that naturally contains 8 to 9 mM of citrate. It is well documented that    
L. diacetylactis and species of Leuconostoc (such as lactis and mesenteroides) 
and W. paramesenteroides contribute, during the ripening of cheese, to the 
production of aroma (generated by the C4 compounds synthesized from citrate 
and glucose) as well as to the formation of the “eyes” produced by the CO2 
released during citrate fermentation [3, 50]. 
 In many dairy products significant number of enterococci are present. For 
example in many cheeses, such as Comté, Cebreiro, Mozzarella, Kefalotyri, 
Serra, Manchego, Feta, and Teleme, enterococci comprise a major part of the 
fresh cheese microbiota, and in some cases they are the predominant micro-
organisms in the fully ripened product. It has been concluded in many reports 
that enterococci may have an important role in cheese production, contributing 
to the ripening and quality of the mature products. Moreover, some researchers 
have suggested that enterococci may play a role in the development of the 
aroma and flavour of many cheeses, probably due to citrate catabolism 
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(reviewed by [51]. However, in contrast, to the extensive studies performed 
with L. diacetylactis and Leuconostoc, the utilization of citrate by Enterococci 
has not been systematically investigated until recently (reviewed in [51]).  
 Transport and citrate metabolism in L. lactis as well as in some species of 
the Leuconostoc genus, constitute a secondary system of proton-motive force 
generation (PMF) [1], in which both components of PMF, trans-membrane 
potential (∆Ψ) and proton gradient (∆pH), are generated in two different 
stages. The ∆Ψ is produced during the antiport catalyzed by CitP of one 
molecule of divalent citrate, that enters into the cell, and one molecule of 
monovalent lactate, that is excreted [1]. The result of this process is the cellular 
uptake of one negative net charge. The ∆pH arises as a consequence of the 
consumption of protons during citrate degradation and also to the fact that the 
end-products (lactate, acetate, CO2, diacetyl, acetoin, etc.) of this catabolism 
are less acidic than citrate [1]. It is well documented that citrate metabolism 
provokes alkalinization of the cytoplasm by consumption of intracellular 
protons, and of the external medium by excretion of less acidic compounds [1]. 
Although in both micro-organisms, it was shown that they are capable of 
generating PMF through this metabolism, it was not enough to support growth 
with citrate as the only source of energy. However, the PMF generated could 
contribute to the growth enhancement during co-metabolism with sugars as 
well as surviving acidic stress conditions. 
 The co-metabolism of glucose and citrate produces different physiological 
effects in homofermentative and heterofermentative LAB. As we describe in 
detail below, in homofermentative LAB citrate utilization has a protective 
effect against acid stress, whereas in heterofermentative LAB “citrolactic” 
fermentation generates one extra mol of ATP per mol of citrate. 
 Bacteria from the genera Lactococcus and Enterococcus as well as             
Lb. plantarum degrade sugars (such us glucose or lactose) by a 
homofermentative pathway forming lactic acid as the main end product (Fig. 7). 
During the co-metabolism of one of these sugars with citrate, large amounts of 
pyruvate are generated which is converted to the production of the C4 aroma 
compounds [51]. L. diacetylactis metabolizes citrate present in milk producing 
high concentrations of diacetyl. In these conditions the metabolism of glucose 
produces lactic acid, which is excreted from the cell in exchange for citrate by 
the antiporter CitP. By means of the homofermentative pathway this organism 
catalyzes the conversion of glucose into lactate producing 2 moles of ATP per 
mol of glucose metabolized. The NAD+ consumed in the first steps of the 
pathway is regenerated during the conversion of pyruvate to lactate 
maintaining the redox balance. In the presence of glucose and citrate, each mol 
of citrate produces one mol of pyruvate without generating NADH. This 
produces an intracellular excess of pyruvate that is diverted to the synthesis of  
 
Aroma production from citrate 17 
 
 
Figure 7. Co-metabolism of citrate and glucose in LAB. Left, homofermentative 
bacteria. Right, heterofermentative bacteria. 
 
α-acetolactate and subsequently to the production of the C4 aroma compounds. 
The end-products of this co-metabolism are lactate diacetyl, acetoin y butanediol. 
In L. lactis, the utilization of citrate results in a growth advantage which is 
evident when the medium has low pH values [34, 43, 52]. In these conditions, 
the presence of citrate provides an efficient use of glucose and also allows the 
cells to resist the high concentrations of lactate produced as a metabolic by-
product. This detoxification effect has been attributed to the efficiency of the 
citrate/lactate antiport catalyzed by CitP [52], which increases its activity during 
the co-metabolism of glucose and citrate [43, 52]. The role of citrate metabolism 
in Enterococci is still unclear. Analysis of metabolic characteristics of 129 En. 
faecalis, En. faecium and En. durans strains indicated strain-to-strain variation 
with regard to citrate metabolism. However, the majority of the En. faecalis 
strains were able to utilize citrate [53, 54]. Interestingly, analysis of sugar and 
citrate metabolisms in En. faecalis and En. durans has revealed that in some 
strains citrate can be utilize in co-metabolism with lactose and not with glucose 
[53, 55]. In these strains citrate can only be utilized when all of the glucose in the 
medium is consumed. Therefore, it has been postulated that citrate utilization is 
controlled by catabolic repression [55, 56]. However, this mechanism has not yet 
been studied at the molecular level. In addition, it has been shown that En. 
faecium is able to co-metabolize glucose and citrate, generating energy 
production and C4 aroma compounds Most of the citrate is consumed during the 
stationary phase, indicating that energy generated by citrate metabolism is used 
for maintenance by this host [57]. 
 Glucose metabolism in Leuconostoc, Oenococcus and Lactobacillus 
strains takes place through the pentose phosphate pathway giving origin to 
heterolactic fermentation characterized by lactate, ethanol and acetate as end 
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products (review in [58] and Fig. 7). In this case the main part of the 
acetylphosphate formed during glucose degradation is reduced to ethanol 
through the phosphoketolase pathway, regenerating NAD+ consumed 
previously. However, the presence of citrate together with glucose provides a 
growth advantage and provokes a shift of the sugar to the heterofermentative 
route. When citrate is present, the NAD+ is regenerated through pyruvate 
reduction to lactate. The acetylphosphate is therefore converted to acetate by 
means of the acetate kinase enzyme, generating an extra mol of ATP [1]. 
Under these conditions of co-metabolism, the name of citrolactic fermentation 
is adequate, since there exists a direct relationship between the substrate 
(citrate) and the end product (lactic acid). On the other hand, the production of 
C4 compounds in Leuconostoc only takes place in conditions of pyruvate 
accumulation, for example at low pHs and in the presence of citrate. In these 
conditions inhibition of LDH occurs, which results in higher levels of 
pyruvate. 
  
8. Enzymes and coding genes involved in the conversion 
of pyruvate into aroma compounds 
 The first step of this pathway is catalyzed by α-ALS. Marrug and 
coworkers [59] determined the sequence of the als gene encoding α-ALS from 
L. lactis DSM20384. Numerous NMR studies, performed in strains of E. coli 
carrying the wild type or mutant als genes from L. lactis, corroborated that this 
gene encodes the α-ALS activity in Lactococcus. The native enzyme is a dimer 
composed of two monomers of 62 kDa, the expected molecular mass for the 
inferred product of the als gene. The enzyme uses thiamine pyrophosphate as 
cofactor and, in concordance with this, a binding motif specific for the cofactor 
was detected [59]. The L. lactis α-ALS is also present in other Gram-positive 
bacteria and other procaryotic organisms [59]. Moreover, acetohydroxyl acid 
synthase (AHAS) also occurs in L. lactis, which has significant homology with 
lactococcal α-ALS at the amino acid level. Interestingly, AHAS is a 
bifunctional enzyme, which yields acetohydroxybutyrate by condensation of 
pyruvate and ketobutyrate, and also catalyzes the conversion of pyruvate into 
α-acetolactate like α-ALS. A transcriptional analysis has revealed that the als 
gene from L. diacetylactis DSM20384 is transcribed from a promoter localized 
63 nucleotides upstream from transcriptional initiation site, generating a 2 kb 
monocistronic mRNA [7]. The measurements of α-ALS levels in cultures of  
L. diacetylactis C17 grown in aerobic, anaerobic or lactose-limiting conditions 
indicated that als gene expression is constitutive [7]. A detailed transcriptional 
analysis of als expression in cultures grown on different physiologic conditions 
has never been made. However, the acid tolerance response of L. cremoris 
MG1363 has been investigated by proteomic analysis, after challenging for a 
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short period at pH 3.5 [60], and an increase of the Als levels was observed 
after acid stress. This result deserves further study to reveal whether expression 
of als is induced at acid pH. The lactococcal als gene is located upstream of 
(though not adjacent to) the cit operon encoding OAD and CL. This suggests 
that during evolution the genes required for the conversion of citrate into α-
acetolactate have been acquired as a genetic cluster. 
 The aldB gene from L. lactis subsp. lactis NCDO2118 was cloned and the 
characterisation of the enzymatic activity of its product confirmed that this 
gene encodes α-ALD [61]. AldB plays a dual role, catalyzing the second step 
of the acetoin biosynthetic pathway, and regulating the pool of α-acetolactate 
in the cell during branched chain amino acid (BCAA) metabolism. This second 
role is very important as these BCAA are essential for protein synthesis, and 
consequently the expression of the enzyme is strictly regulated at both 
transcriptional and post-transcriptional levels [6, 61, 62]. The aldB is located 
(Fig. 8) downstream of genes encoding the enzymes involved in the 
biosynthesis of BCAA (leucine,  valine  and  isoleucine) and  precedes  aldR 
gene  encoding  a  putative  regulator, whose function has not been completely 
elucidated [61]. The transcriptional analysis of aldB expression revealed that 
this gene forms an operon with leu, ilv and aldR genes. Interestingly, aldB is 
transcribed from three different promoters: P1, P2 and P3. Isoleucine represses 
transcription from P2 and leucine affects transcription from P1 by attenuation. 
In addition, α-ALD is allosterically activated by leucine [6]. Goulpin-Feullerat 
et al. [62] showed that expression of aldB is controlled at the post-
transcriptional level by a secondary structure, which blocks the ribosomal 
binding site of the gene and interferes with AldB synthesis. This structure only 
exists in the aldB transcripts synthesized from P1 and P2. The expression from 
P3 is not affected by the presence of amino acids in the growth medium. 
However, transcriptional activation of P3 by factors connected with citrate 
metabolism has not been investigated. The overall regulation could have 
evolved to increase significantly the levels of AldB, without having an impact 
in the BCAA biosynthesis and deserves further investigation. The sequence 
comparison of the products of aldB from L. lactis strains NCDO2118 [61], 
MG1363 [63] and IL1403 [35] revealed that they are almost identical 
polypeptides, each of 236 amino acids, and that this class of enzymes is highly 
conserved in Gram-positive and Gram-negative bacteria. Furthermore, the 
aldC gene occurs in strain IL1403, whose product may be an isoenzyme of    
α-ALD. In L. cremoris, the aldB gene is also located adjacent to the ilv operon 
and may be subject to the same regulation of expression. Interestingly, in the  
L. cremoris SK11 strain, there exists an extra-chromosomal copy of aldB (98% 
identity) located on plasmid pSK11B [64], in addition to a chromosomal copy 
of aldC, which could be acting as an ALDs. 
 







Figure 8. Organization and transcription of the L. diacetylactis leu-ilv-ald cluster. 
The genes and promoters are depicted. See details in the text. 
 
 DAR catalyzes two stages of citrate metabolism: it converts diacetyl into 
acetoin and also reduces acetoin to 2, 3-butanediol. The conversion of 2,3-
butanediol into acetoin is catalyzed by BDH, and in L. diacetylactis two proteins 
seem to possess this enzymatic activity as well as DAR activities [8]. Rattray, et 
al. characterized the DAR of Lc. pseudomesenteroides encoded by the plasmidic 
butA gene [65,66]. Bioinformatic analysis performed using the butA gene of    
Lc. pseudomesenteroides, allowed us to identify the butA gene in the IL1403 
genome, whose product shares 81% homology with the ButA from Leuconostoc. 
Preceding the L. diacetylactis IL1403 butA is located the butB gene, whose 
product is annotated as BDH in the lactococcal genome data bank, and belongs 
to the Zn-containing alcohol dehydrogenase superfamily PTHR11695.         
The genes butB and butA are also linked in the L. cremoris (MG1363 and 
SK11) chromosomes. However, in other species of LAB, such as Lc. 
pseudomesenteroides [66] butA is carried on plasmids, which could facilitate its 
horizontal transfer. The two DARs purified from lactococcal cells, both have less 
affinity for 2,3-butanediol than for diacetyl and acetoin as substrate and, both 
have an optimal alkaline and acidic pH, respectively, for its BDH and DAR 
activities [8]. Therefore, it is tempting to postulate that at acidic pH an increase 
of 2,3-butanediol results, though still allowing significant amounts of acetoin; 
this has been observed in L. diacetylactis strains [5]. This effect may contribute 
to the regulation of the NADH/NAD ratio by the reversible inter-conversion of 
acetoin and 2,3-butanediol. A dar gene exists in the MG1363 and SK11 
chromosomes (but not in IL4103 genome) whose product has 46% identity with 
that of butA. Inactivation of dar in the chromosome of L. cremoris MG1363 [67] 
resulted in a decrease of the DAR activity, confirming the enzymatic identity of 
the gene product. The existence of three DAR in L. cremoris subsp., together 
with its lack of CL and OAD, could contribute to the lower production of acetoin 
compared to L. diacetylactis. Moreover, the L. lactis subsp. is prefered as an 
industrial starter culture, since these flavours compounds are very valuable in 
improving food quality. 
 It should be noted that transcriptional analyses of DAR enzymes have not 
been yet investigated. Thus, several factors remain to be elucidated such as the 
control of expression of the coding genes, as to demonstrate whether butBA 
constitute an operon, and if really dar is the second gene of a putative operon 
formed by seven genes. 
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9. Conclusions and perspectives 
 The biochemistry and bioenergetics of citrate transport and its subsequent 
conversion into pyruvate is well understood in most of dairy LAB. It has been 
demonstrated in the L. lactis homofermentative LAB that citrate metabolism is 
involved in the adaptative response to acidic stress and it contributes to 
homeostasis. However, the mechanism of activation of the cit promoter at acidic 
pH is still unknown. No evident operators required for binding of specific 
regulators have been detected in the promoter regions. Remarkably, no stress 
sigma factor of the RNAP is found in the L. lactis genome, which necessarily 
points to an alternative regulatory mechanism for lactococcal cit promoters, 
which has still to be elucidated. 
 In species of W. paramesenteroides and Leuconostos and probably other 
heterofermentative LAB, citrate metabolism is mainly devoted to energy 
generation and it is activated at the transcriptional level by the CitI regulator and 
citrate. The role, if any, of the lactococcal CitI in the induction of the cit operon 
at acidic pH requires further investigation. 
 Synthesis of aroma compounds from citrate via pyruvate is commercially 
important for the dairy and other food industries, but there is a gap between the 
knowledge of the biochemistry of the C4-compound biosynthetic pathway and a 
complementary understanding of the genetics and regulation of the pathway. The 
recent determination of the entire genomes of various LAB provides a valuable 
tool to identify genes encoding enzymes that potentially could be involved in the 
pathway, and even to postulate pathways in silico, as for example has been done 
for the citrate catabolism of Lb. casei [68]. This will contribute in the near future 
to a better understanding of citrate utilization by species of Enterococcus and 
Lactobacillus. 
 Finally, due to the importance of diacetyl production to the dairy industries, 
the use of metabolic engineering has been investigated, which has allowed the 
generation of recombinant L. lactis strains able to overproduce diacetyl from 
glucose (reviewed in [69] and see details in chapter 9). However, as far as we 
know there is not any product on the market containing these bacteria either in 
Europe or in USA, due to current regulations on the use of genetically 
manipulated micro-organisms and also, to the fact that these strains, lacking the 
citrate transporter, do not produce very high levels of diacetyl. Presumably, 
transfer of the plasmid encoding the citrate permease to the L. lactis strains will 
significantly increase their ability to produce diacetyl. This strategy is showing 
promising results in the generation of a food-grade Lactobacillus casei diacetyl 
producer strain [70]. It is expected that this, and other approaches will be used to 
generate diacetyl overproducing strains in other LAB such as Enterococci. 
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